← All Sponsors
SPONSOR

University of Oxford

Total Trials
11
Recruiting
11
Phases
EARLY_Phase 1, Phase 1, Phase 3, Phase 4, Phase 2

University of Oxford is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Type 1 Diabetes (T1D), Registry, Pre-diabetes, Screening.

The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Oxford

How many clinical trials has University of Oxford sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by University of Oxford, of which 11 are actively recruiting participants. These trials cover conditions including Type 1 Diabetes (T1D), Registry, Pre-diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Oxford research focus on?
University of Oxford clinical trials span Type 1 Diabetes (T1D), Registry, Pre-diabetes, Screening, Emotional Processing, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Oxford clinical trial?
To participate in a University of Oxford trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Oxford trials with current recruitment status updated daily.

Clinical Trials by University of Oxford

NCT07125365
Recruiting

UK Islet Autoantibody Registry

Type 1 Diabetes (T1D)
NCT06636812 EARLY_Phase 1
Recruiting

Losartan and Emotional Processing in Young People

Emotional Processing
NCT07215195
Recruiting

Neuropsychiatric Outcomes and Disrupted Sleep Following Acquired Brain Injury

Acquired Brain Injury (Including Stroke)
NCT07424781
Recruiting

Fluoxetine on Emotional Experience (FLEX) Study

Depression - Major Depressive Disorder
NCT03762499
Recruiting

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

Hypertension
NCT07511829
Recruiting

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

MDS (Myelodysplastic Syndrome)
NCT05942287
Recruiting

The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Heart Failure
NCT06958198 Phase 1
Recruiting

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

Malaria,Falciparum
NCT06778564 Phase 3
Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Psychosis
NCT06068530 Phase 4
Recruiting

Mass Vaccine and Drug Administration, Bangladesh

Plasmodium Falciparum Malaria
NCT06488300 Phase 2
Recruiting

Assessing Antiviral Treatments in Early Symptomatic RSV

Respiratory Syncytial Virus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology